Coinspeaker AZN Shows Strong H1 Performance as AstraZeneca Advances COVID-19 Vaccine Clinical TrialsWith the company's ongoing late-stage clinical trials and its impressive H1 performance results, AstraZeneca (AZN) stock jumped in the pre-market.AZN Shows Strong H1 Performance as AstraZeneca Advances COVID-19 Vaccine Clinical Trials